Blank J, Mangurten H
Am J Pediatr Hematol Oncol. 1984 Summer;6(2):197-203. doi: 10.1097/00043426-198406020-00014.
Increasingly, transfusions of component blood products are used in the setting of the neonatal intensive care unit. There is a need to analyze the indications and potential complications of this therapy critically. We review here the problems primarily unique to the neonatal population and suggest an approach to the transfusion requirements of this group. Specifically, we discuss the rationale, indications and complications of red cell, granulocyte, and platelet transfusions in these patients. Discussion of exchange transfusion and the particular blood banking requirements of these patients will be reviewed in subsequent articles.
在新生儿重症监护病房中,成分血制品的输注越来越普遍。迫切需要对这种治疗方法的适应证和潜在并发症进行严格分析。我们在此回顾主要针对新生儿群体的独特问题,并提出一种针对该群体输血需求的方法。具体而言,我们将讨论这些患者红细胞、粒细胞和血小板输注的基本原理、适应证及并发症。换血疗法及这些患者特殊的血库要求将在后续文章中进行讨论。